Form 4: Ingevity Corp Director J. Kevin Willis Reports Stock Transactions

Director J. Kevin Willis reports acquisition of deferred stock units and vested DSUs, along with a power of attorney update.

Summary

• J. Kevin Willis, a director of Ingevity Corp, filed a Form 4 detailing changes in beneficial ownership.
• On May 1, 2025, Willis acquired 4,057 deferred stock units (DSUs) and 151 vested DSUs.
• The 4,057 DSUs were granted in lieu of the annual non-employee director restricted stock unit grant and will vest on May 1, 2026.
• These DSUs will settle into common stock upon termination of board service.
• The 151 vested DSUs were granted in lieu of quarterly director fees and will also settle into common stock upon termination of board service.
• Willis also disposed of 7,023 common stock units.
• Following these transactions, Willis beneficially owns 7,174 shares of common stock.
• A Limited Power of Attorney was executed on April 29, 2025, appointing Ryan C. Fisher and Mavis G. Huger as attorneys-in-fact for SEC reporting purposes.

Sentiment

Score: 6

Explanation: Neutral sentiment as the document primarily reports routine transactions and updates a power of attorney. There are no explicit positive or negative indicators, but the disposal of shares could be viewed with slight caution.

Positives

• The acquisition of DSUs reflects continued director compensation and alignment with company performance.

Negatives

• The disposal of 7,023 common stock units could be interpreted negatively, although the reason for disposal is not specified.

Risks

• The Form 4 filing itself doesn't present inherent risks, but market perception of director transactions can influence stock price.

Future Outlook

The document does not contain specific forward-looking statements, but the vesting of DSUs in 2026 suggests continued board service.

Industry Context

Form 4 filings are standard disclosures for corporate insiders and provide transparency into their transactions in company stock.

Comparison to Industry Standards

• Form 4 filings are a standard regulatory requirement for all publicly traded companies in the United States, ensuring transparency of insider transactions.
• Companies like Eastman Chemical Company (EMN) and WestRock Company (WRK), which operate in similar sectors, also regularly file Form 4 reports for their executives and directors.
• The structure and content of this Form 4 are consistent with SEC guidelines and industry norms.

Stakeholder Impact

• Shareholders may be interested in the transactions of company directors as an indicator of confidence in the company's future.

Key Dates

Keywords

Form 4, Ingevity Corp, Director, Beneficial Ownership, Deferred Stock Units, DSUs, SEC, Power of Attorney, NGVT